A Multicenter, Phase I-II Trial of Gemcitabine Plus Oxaliplatin and Nab-paclitaxel in Subjects With Advanced (Unresectable or Metastatic) Biliary Tract Cancer
Latest Information Update: 30 Jul 2020
At a glance
- Drugs Gemcitabine (Primary) ; Oxaliplatin (Primary) ; Paclitaxel (Primary)
- Indications Cholangiocarcinoma; Gallbladder cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Jul 2020 Planned primary completion date changed from 1 May 2020 to 1 Sep 2020.
- 25 Sep 2018 New trial record